US Stock MarketDetailed Quotes

CUE Cue Biopharma

Watchlist
  • 0.670
  • -0.033-4.73%
Close Jul 26 16:00 ET
32.59MMarket Cap-626P/E (TTM)

Cue Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cue Biopharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

1.72M

+818.18%
EPS(YoY)

-0.25

+13.79%
Analyst Rating

Strong Buy

Jul 26, 2024

Cue Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.293M--
--2024/Q2-- / 1.289M--
--2024/Q11.717M / 1.213M--
--2023/Q41.821M / 1.567M--
Nov 9, 20232023/Q32.100M / 1.120M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.293M--
--2024/Q2-- / 1.289M--
--2024/Q11.717M / 1.213M--
--2023/Q41.821M / 1.567M--
Nov 9, 20232023/Q32.100M / 1.120M--

Unlock Free Earnings Estimates

Cue Biopharma Earnings Reports

  • Cue Biopharma | 10-Q: Quarterly report

    May 9 16:05 ET

  • Cue Biopharma | 10-K: Annual report

    Mar 28 22:41 ET

  • Cue Biopharma | 10-Q: Q3 2023 Earnings Report

    Nov 3, 2023 16:15 ET

  • Cue Biopharma | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 26, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg